Long Term Open Label Continuation Study
NCT00195650
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
846
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
Adalimumab
Sponsor
Abbott